25
Views
0
CrossRef citations to date
0
Altmetric
Original Paper

Treatment options for real-life patients

Pages 37-41 | Published online: 12 Jul 2009

REFERENCES

  • Kirsch I, Moore T, Scoboria A, Nicholls S (2002) The emperor’s new drugs: an analysis of antidepressant medication data submitted to the U.S. food and drug administration. Prev Treat 5: 23.
  • Khan A, Khan S, Brown WA (2002) Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol 5: 193–7.
  • Hypericum Depression Trial Study Group (2002) Effect of Hypericum perforatum (St John’s Wort) in major depressive disorder: a randomized controlled trial. J Am Med Assoc 287: 1807–14.
  • Williams JW Jr, Mulrow CD, Chiquette E et al (2000) A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 132: 743–56.
  • Anderson IM (2000) Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. J Affect Disord 58: 19–36.
  • Robinson LA, Berman JS, Neimeyer RA (1990) Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research. Psychol Bull 108: 30–49.
  • Depression Guideline Panel (1993) Depression in primary care. Vol Treatment of major depression. Rockville, MD: US Department of Health and Human Services. (Clinical practice guidelines, No 5. AHCPR Publication No 93-0551.)
  • Walsh BT, Seidman SN, Sysko R, Gould M (2002) Placebo response in studies of major depression: variable, substantial, and growing. J Am Med Assoc 287: 1840–7.
  • Parker G, Anderson IM, Haddad P (2003) Clinical trials of antidepressant medications are producing meaningless results. Br J Psychiatry 183: 102–4.
  • Parker G (2000) Classifying depression: should paradigms lost be regained? Am J Psychiatry 157: 1195–203.
  • Parker G, Roy K, Eyers K (2003) Cognitive behavior therapy for depression? Choose horses for courses. Am J Psychiatry 160: 825–34.
  • Keller MB, McCullough JP, Klein DN et al (2000) A com- parison of nefazodone, the cognitive behavioral-analysi system of psychotherapy, and their combination for the treatment of chronic depression. New Engl J Med 342: 1462–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.